These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 34066371)

  • 1. Calcium Dyshomeostasis in Alzheimer's Disease Pathogenesis.
    Cascella R; Cecchi C
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
    Guan PP; Cao LL; Wang P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium signaling in Alzheimer's disease & therapies.
    Tong BC; Wu AJ; Li M; Cheung KH
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
    Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
    Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease.
    Panes-Fernandez J; Godoy PA; Gavilan J; Ramírez-Molina O; Burgos CF; Marileo A; Flores-Núñez O; Castro PA; Moraga-Cid G; Yévenes GE; Muñoz-Montesino C; Fuentealba J
    Biomed Pharmacother; 2023 Jun; 162():114596. PubMed ID: 36989728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-Beta Modulates Low-Threshold Activated Voltage-Gated L-Type Calcium Channels of Arcuate Neuropeptide Y Neurons Leading to Calcium Dysregulation and Hypothalamic Dysfunction.
    Ishii M; Hiller AJ; Pham L; McGuire MJ; Iadecola C; Wang G
    J Neurosci; 2019 Oct; 39(44):8816-8825. PubMed ID: 31537707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium dysregulation in Alzheimer's disease.
    Bojarski L; Herms J; Kuznicki J
    Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
    Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
    Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Abeta-induced calcium dysregulation in the pathogenesis of Alzheimer's disease.
    Small DH; Gasperini R; Vincent AJ; Hung AC; Foa L
    J Alzheimers Dis; 2009; 16(2):225-33. PubMed ID: 19221414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer's Disease.
    Baracaldo-Santamaría D; Avendaño-Lopez SS; Ariza-Salamanca DF; Rodriguez-Giraldo M; Calderon-Ospina CA; González-Reyes RE; Nava-Mesa MO
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium Dyshomeostasis and Alzheimer's Disease].
    Qi S; Yuan Y; Yang W; Su JY; Hao LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Aug; 46(4):592-602. PubMed ID: 39223024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
    Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH
    Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
    Mattson MP; Chan SL
    J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.